AI brief of an SEC Form 8-K · Universal Health Services (UHS)

Universal Health Services completes $1.1 billion of senior secured notes due 2031 and 2036

Neutral Impact 3 of 5 financing Written later

On August 20, 2026, Universal Health Services completed a public offering of $600 million of 5.500% senior secured notes due 2031 and $500 million of 6.000% senior secured notes due 2036. The notes are guaranteed by subsidiaries and secured by first-priority liens on certain assets, ranking equally with the company's senior secured credit facility and five series of existing secured notes. The filing adds $1.1 billion of secured debt, and notes that some underwriter affiliates will receive proceeds as repayment of revolving credit facility borrowings.

Key points

  • $600 million 5.500% senior secured notes mature September 1, 2031; callable before August 1, 2031 at par plus accrued interest and a make-whole premium.
  • $500 million 6.000% senior secured notes mature September 1, 2036; callable before June 1, 2036 at par plus accrued interest and a make-whole premium.
  • Interest is payable semi-annually on March 1 and September 1, starting March 1, 2027.
  • Moody's and S&P rated the notes investment grade at issuance, but the filing says collateral release conditions were not met as of that date.

The filing

CompanyUniversal Health Services (UHS)
Form8-K, current report
Filed with the SECAug 21, 2026, 7:58 AM ET
Accession number0001193125-26-359953

Items reported: 1.01 Material Definitive Agreement2.03 New Direct Financial Obligation

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 12:56 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 21, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.